Classic signaling pathway holds key to prostate cancer progression — ScienceDaily
source : http://www.sciencedaily.com/releases/2013/12/131220121046.htm
source : http://www.sciencedaily.com/releases/2013/12/131220121046.htm
source : http://www.sciencedaily.com/releases/2014/01/140109175454.htm
source : http://www.sciencedaily.com/releases/2014/01/140120085058.htm
"The lethal part of cancer is its metastasis so understanding how metastasis occurs is critical," says senior study author Max S. Wicha, M.D., Distinguished Professor of Oncology and director of the University of Michigan Comprehensive Cancer Center…
The research team focuses on primary effusion lymphoma (PEL), an aggressive and deadly variant of diffuse large B-cell lymphoma that frequently occurs in people infected with HIV. Though scientists have known that the Kaposi’s sarcoma-associated herpesvirus (KSHV) causes PEL, development of effective therapies has proven difficult. PEL tumors arise within body cavities and progress rapidly with an average survival of around 6 months. Combination chemotherapy represents the current standard of care for PEL, but side effects (including bone marrow suppression) and drug resistance (generated through virus-associated mechanisms) continue to limit the effectiveness of standard therapy…
The study used mathematical models to calculate the long-term effect of the seminal report, and subsequent anti-smoking measures, over the past half-century. These cumulative efforts have significantly reshaped public attitudes and behaviors concerning cigarettes and other forms of tobacco, note the researchers. First author Theodore R…
"The first step towards preventing lung cancer is avoiding cigarettes which cause 85 percent of diagnoses," said Dr. David Madtes, director of the Lung Cancer Early Detection and Prevention Clinic at SCCA. …
The most advanced version of vβ3-integrin antagonists failed clinical trials to treat aggressive forms of brain cancer. But research published today in the American Heart Association’s journal Circulation Research shows that targeting the protein in question could still be vital in stopping the growth of tumors. Not least because the drugs targeting it cause minimal side effects compared to other drugs — which can cause bleeding in the gut and high blood pressure. tumors must recruit their own blood supply to grow beyond a very small size…
Chimeric antigen receptor T cells (CAR T cells) are a form of personalized cell therapy that uses immune cells called T cells from patients. After T cells are harvested from a patient, they are engineered to bear a molecule that allows them to attach to a specific protein carried by the patient’s cancer cells and to be triggered to kill the cancer cells when they do so. …
Presented at a poster session at the 2013 CTRC-AACR San Antonio Breast Cancer Symposium by Carlos Barcenas, M.D., assistant professor in MD Anderson’s Breast Medical Oncology, the study is the first to look at the issue of over-use of staging procedures, including imaging and tumor markers in the diagnosis setting, specifically in younger, early-stage breast cancer patients. Over-testing and unnecessary procedures extends beyond cancer care across the healthcare continuum. …